Epic Pharma Company Profile
What is the competitive landscape for EPIC PHARMA
EPIC PHARMA has two hundred and three approved drugs.
There is one tentative approval on EPIC PHARMA drugs.
Summary for Epic Pharma
| US Patents: | 0 |
| Tradenames: | 171 |
| Ingredients: | 160 |
| NDAs: | 203 |
| Patent Litigation for Epic Pharma: | See patent lawsuits for Epic Pharma |
Drugs and US Patents for Epic Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epic Pharma Llc | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 212990-003 | Sep 30, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Epic Pharma Llc | DIFLUPREDNATE | difluprednate | EMULSION;OPHTHALMIC | 207284-001 | May 14, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Epic Pharma Llc | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | glipizide; metformin hydrochloride | TABLET;ORAL | 077507-001 | Oct 27, 2005 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Epic Pharma Llc | NANDROLONE DECANOATE | nandrolone decanoate | INJECTABLE;INJECTION | 087519-001 | Sep 28, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Epic Pharma Llc | NEMBUTAL SODIUM | pentobarbital sodium | CAPSULE;ORAL | 083245-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Epic Pharma Llc | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 210675-002 | Oct 16, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Epic Pharma Llc | CLINDAMYCIN PHOSPHATE | clindamycin phosphate | SWAB;TOPICAL | 065513-001 | Jun 17, 2010 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
